Arrowhead Pharmaceuticals, Inc. (ARWR)
Arrowhead Pharmaceuticals Market Cap : 8.905B for Feb. 20, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Sarepta Therapeutics, Inc. | 1.978B |
| Sanofi | 114.05B |
| Eli Lilly & Co. | 952.34B |
| Cidara Therapeutics, Inc. | 6.962B |
| Celcuity, Inc. | 4.849B |
Market Cap Related Metrics
| PE Ratio | 41.34 |
| PS Ratio | 8.014 |
| Price to Book Value | 15.67 |
| Price to Free Cash Flow | 26.74 |
| Price | 63.59 |
| Earnings Yield | 2.42% |
| Operating PE Ratio | 29.09 |
| Normalized PE Ratio | 41.34 |